Pelvic Floor Products Market: By Product Type (Stimulators, Exerciser, Others), By Application (Urinary Incontinence, Sexual Dysfunction, Neurodegenerative Diseases), By End User (Hospitals, Ambulatory Surgical Centers, Specialized clinics, Homecare setting), and Country    

Pelvic Floor Products Market size was valued at USD 325.38 Million in 2023 and is poised grow at a CAGR of 6.9% from 2024 to 2030. The market is driven by the various factors in which there is an increasing prevalence of pelvic floor disorders (PFDs), rising awareness of PFDs, technological advancements, and growing acceptance of home-based treatments. PFDs are a group of conditions that affect the muscles and connective tissues of the pelvic floor. They are more common in women but can also affect men.

The prevalence of PFDs increases with age and is estimated to affect up to one in three women. Common PFDs include urinary incontinence, fecal incontinence, and pelvic organ prolapse. There is a growing awareness of PFDs, due to increased media attention and educational campaigns by patient advocacy groups. This is leading to more people seeking diagnosis and treatment for PFDs. There are new and innovative pelvic floor products being developed all the time. These products are more effective and easier to use than ever before. For instance, there are new electrical stimulation devices that can help to strengthen the pelvic floor muscles. There is a growing acceptance of home-based treatments for PFDs. This is because these treatments are often more convenient and affordable than traditional treatments. Pelvic floor products can be used at home, which makes them a good option for people who are too busy or embarrassed to see a doctor. However, the constraints of the market need to be addressed, the stigma associated with PFDs, reimbursement issues, and lack of awareness among healthcare providers.

Pelvic Floor Products Market Key Developments:

• In November 2023, CooperSurgical, a subsidiary of CooperCompanies, has recently expanded its medical device portfolio with the acquisition of select assets from Cook Medical. This acquisition, which was finalized, is primarily focused on the obstetrics, doppler monitoring, and gynecology surgery markets. The purchase price was $300 million.
• In February 2020, LABORIE Medical Technologies, acquired Clinical Innovations leading global provider of clinician-preferred medical devices for the labor & delivery (L&D) and neonatal intensive care unit (NICU) specialties for an enterprise value of $525 million.